Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines - Wikidata - wikimedia - TriplyDB

Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines

Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines

http://www.wikidata.org/entity/Q33437936

about

Mitoxantrone for multiple sclerosis Mitoxantrone for multiple sclerosis A study of oligoclonal band negative multiple sclerosis.Statistical power of MRI monitored trials in multiple sclerosis: new data and comparison with previous results.Adaptive functional changes in the cerebral cortex of patients with nondisabling multiple sclerosis correlate with the extent of brain structural damage.Quantitative magnetization transfer imaging of pre-lesional white-matter changes in multiple sclerosis.Evaluating the Role of Corticosteroid Pulse Therapy in Patients With Secondary Progressive Multiple Sclerosis Receiving Mitoxantrone: A Double Blind Randomized Controlled Clinical Trial.Cerebellar volume as imaging outcome in progressive multiple sclerosis Brain reserve and cognitive reserve protect against cognitive decline over 4.5 years in MS.Total lymphoid irradiation in multiple sclerosis Magnetisation transfer ratios and transverse magnetisation decay curves in optic neuritis: correlation with clinical findings and electrophysiology Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteria.Disease-modifying drugs reduce cortical lesion accumulation and atrophy progression in relapsing-remitting multiple sclerosis: results from a 48-month extension study Brain involvement in systemic immune mediated diseases: magnetic resonance and magnetisation transfer imaging study Changes in the normal appearing brain tissue and cognitive impairment in multiple sclerosis.Electroencephalographic coherence analysis in multiple sclerosis: correlation with clinical, neuropsychological, and MRI findings.Relative contributions of brain and cervical cord pathology to multiple sclerosis disability: a study with magnetisation transfer ratio histogram analysis Magnetisation transfer ratio and mean diffusivity of normal appearing white and grey matter from patients with multiple sclerosis.A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis Regional Distribution and Evolution of Gray Matter Damage in Different Populations of Multiple Sclerosis Patients Phase-Sensitive Inversion-Recovery MRI Improves Longitudinal Cortical Lesion Detection in Progressive MS.An algorithm for automatic segmentation and classification of magnetic resonance brain images MRI lesion volume measurement in multiple sclerosis and its correlation with disability: a comparison of fast fluid attenuated inversion recovery (fFLAIR) and spin echo sequences.Precision and reliability for measurement of change in MRI lesion volume in multiple sclerosis: a comparison of two computer assisted techniques.Soluble E-selectin in multiple sclerosis: raised concentrations in patients with primary progressive disease.Emerging treatments in multiple sclerosis: azathioprine and mofetil.Magnetic resonance imaging changes with recombinant human interferon-beta-1a: a short term study in relapsing-remitting multiple sclerosis.Variation between observers in classifying multiple sclerosis The treatment of chronic progressive multiple sclerosis with cladribine.MRI monitoring of immunomodulation in relapse-onset multiple sclerosis trials.Immunotherapy of multiple sclerosis: the state of the art.Ingested Type I Interferon-State of the Art as Treatment for Autoimmunity Part 2 Relationship of triple dose contrast enhanced lesions with clinical measures and brain atrophy in early relapsing-remitting multiple sclerosis: a two-year longitudinal study.Frontal parenchymal atrophy measures in multiple sclerosis.Single nucleotide polymorphisms in the FOXP3 gene are associated with increased risk of relapsing-remitting multiple sclerosis.Combinations of drugs.Triple dose of gadolinium-DTPA and delayed MRI in patients with benign multiple sclerosis.Multiple sclerosis: diagnostic optimism.Low degree of cortical pathology is associated with benign course of multiple sclerosis.Randomized study of interferon beta-1a, low-dose azathioprine, and low-dose corticosteroids in multiple sclerosis.

P2860

Q24202866-DFC4DAC4-94E7-4BFD-BE5B-3C95AA2738E9 Q24245404-C260A11F-4768-426E-BC25-633BADF391A0 Q29544969-BD7091F5-D6DD-463B-999C-40A329321FBC Q30573085-4909196F-5A15-46E9-8EBC-F2C8FBD971AC Q30679381-75FFD124-8FC2-475D-99E5-8C7081E36711 Q30753871-E6503966-50B2-4C94-836A-43A788A9533D Q31023281-32CEB5C2-5167-416F-B698-E5718356A800 Q33596769-A90EC3E3-EA6F-4F46-B921-7EF051114268 Q33672609-97239E60-B7FA-4EF0-A880-E0BC748CE161 Q33731206-75FC9791-7F86-44E4-88FB-FAB81E5228B0 Q33734692-533A1D2F-D5A4-467A-A345-DAAA50B6E281 Q34064209-1CC10BB6-D27A-4D19-8468-CA6932684DB8 Q35159288-14570511-01F9-44C9-A0BD-BE4509792F06 Q35455167-671EA12E-914D-4AB2-A91A-A5249E434259 Q35455319-2925731D-AF47-4B0A-ADA3-CD6C3991A406 Q35458618-98E78932-B009-4337-A631-68A0C32AB814 Q35459896-909A9829-FF6D-4EAB-85D8-494CE0DEAB57 Q35461315-4768B21A-902C-4F9D-A338-64F6524BC684 Q35462222-FF881F30-08A6-4BC6-B87C-E0F80A88AA48 Q35744057-0A601952-7730-449F-A919-D774FCA8264C Q35965843-5FB24CB0-173E-4CB1-B568-2EEABEA0D059 Q36262820-2C53CA0C-572E-4530-A1C2-6E7D61B009F1 Q36317785-9C5F79F0-ACF1-4E9F-BD97-1C2C00C49850 Q36318391-2C3C1FD3-9B1A-45A9-B541-762A58ACC116 Q36885953-7F6700C6-D0BA-4795-98C9-EE6A3E989577 Q36887923-53678835-FCF7-4458-A887-D17FD46C01AA Q36896777-B77BE1E3-25BE-40DE-8247-5EC54F760CA8 Q36898103-4E7A31CE-1986-44FB-91EF-DD312595FA61 Q37725229-58A07525-978A-472A-AAEE-D2C371279A9C Q37964985-44CAE1E9-6056-4545-B3E8-1D09D1688BD9 Q38083041-9184609D-AB78-46AB-B990-F197991D041F Q39948674-8C76B347-C412-4EC7-9C26-5945341FB6D8 Q40222496-2DF96BC2-1733-4536-8015-462FA885765B Q40477265-5F4EC18F-40CE-43CA-8C9C-E0F28534DAC6 Q40507582-089817A1-2880-4F89-B88F-6B07B8B739F3 Q40933997-9CFA7503-18D6-475B-805C-F19F5B05136F Q41353226-1BAAFC9C-3C3D-4246-BE71-915C591052D3 Q42765249-E1B42D20-5060-43F9-9C49-050ADB8F6D36 Q44584762-B5C665AE-8692-4CE3-ACA2-B8654FD5D7DD Q45998751-933229C9-9020-4AED-AA13-7475E371B72B

P2860

Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines

http://www.wikidata.org/entity/Q33437936

description

1991 nî lūn-bûn

@nan

1991 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

1991 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

1991年の論文

@ja

1991年学术文章

@wuu

1991年学术文章

@zh-cn

1991年学术文章

@zh-hans

1991年学术文章

@zh-my

1991年学术文章

@zh-sg

1991年學術文章

@yue

name

Magnetic resonance imaging in ...... s: concerted action guidelines

@ast

Magnetic resonance imaging in ...... s: concerted action guidelines

@en

type

label

Magnetic resonance imaging in ...... s: concerted action guidelines

@ast

Magnetic resonance imaging in ...... s: concerted action guidelines

@en

prefLabel

Magnetic resonance imaging in ...... s: concerted action guidelines

@ast

Magnetic resonance imaging in ...... s: concerted action guidelines

@en

P1433

Q33437936-762088FE-EDF9-42D5-A440-4F083389031C

P1476

Q33437936-BECC6C3F-E841-43C4-9EA4-066F04C791D4

P2093

Q33437936-1757FF35-313C-42BF-AC27-8AFB8F00BCD2

Q33437936-58DE0A8E-2143-469A-9F03-D1A1657FDC47

Q33437936-A040FB05-FEB9-4842-BB5D-9D22380A4093

Q33437936-E316FA91-0EEF-4227-849A-E3FF01B2639A

Q33437936-FA2597F0-C07E-4A31-84AB-328125DCB735

Q33437936-FC137E07-F913-452A-B738-326A15C71C8D

P2860

Q33437936-002C8829-1691-47B5-894D-4B186ADA237C

Q33437936-06B23308-C99C-4BB6-A6DE-A7666093800C

Q33437936-2368D440-C204-48DF-8250-C3DECC9F5631

Q33437936-2A5603E9-D1D1-4479-8AF4-B0CED3A48AC8

Q33437936-2C42DDC1-1419-4BFE-8F96-39FE8002F6C7

Q33437936-305F9DD0-4523-45BF-B88D-1A608C7D1E7D

Q33437936-3FDAFD2E-2278-481A-B7D5-AEF5B1D6E764

Q33437936-40118F7F-B7DA-48B3-87FF-240EDF4AF784

Q33437936-4E63B69E-18F6-40A9-8B79-5F6C13B9E8DC

Q33437936-4FDFD908-936C-4630-B7B5-7B039ABF6B78

P304

Q33437936-363E3926-64AC-4C69-AB48-D088E48849CF

P31

Q33437936-C34E5053-A690-4556-81DF-EA61D4BAD3A4

P356

Q33437936-142D649D-E52D-432A-9423-426F8674919F

P407

Q33437936-D0BEA178-A02F-4D18-8B61-649767E6C1D1

P433

Q33437936-3786289F-83BC-41A4-ACD0-5EB5FB71D801

P478

Q33437936-3E54FF33-07D7-4A25-840C-8F92B206E107

P577

Q33437936-6DC9A978-9ECC-407D-946D-38AD335E8227

P5875

Q33437936-93385B14-8947-494F-831E-EA67FF25BC67

P698

Q33437936-4E050C1F-E72D-4922-9881-874DAC49E0E7

P921

Q33437936-DFD412C1-1D99-4C24-8EF2-7B20DC69826F

P932

Q33437936-2010EA8B-3BCF-4659-94C1-C802700FC688

P356

P1433

Journal of Neurology, Neurosurgery and Psychiatry

P1476

Magnetic resonance imaging in ...... s: concerted action guidelines

@en

P2093

Barkhof F

http://www.w3.org/2001/XMLSchema#string

Berry I

http://www.w3.org/2001/XMLSchema#string

Kappos L

http://www.w3.org/2001/XMLSchema#string

Miller DH

http://www.w3.org/2001/XMLSchema#string

Scotti G

http://www.w3.org/2001/XMLSchema#string

Thompson AJ

http://www.w3.org/2001/XMLSchema#string

P2860

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

Changes within the "normal" cerebral white matter of multiple sclerosis patients during acute attacks and during high-dose cortisone therapy assessed by means of quantitative MRI.

Proton magnetic resonance spectroscopy of human brain in vivo in the evaluation of multiple sclerosis: assessment of the load of disease.

Magnetic resonance: perfusion and diffusion imaging.

Patterns of disease activity in multiple sclerosis: clinical and magnetic resonance imaging study.

In vivo determination of T1 and T2 in the brain of patients with severe but stable multiple sclerosis.

Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis.

Computed tomography in acute disseminated encephalomyelitis.

Heterogeneity of blood-brain barrier changes in multiple sclerosis: an MRI study with gadolinium-DTPA enhancement.

Duration and selectivity of blood-brain barrier breakdown in chronic relapsing experimental allergic encephalomyelitis studied by gadolinium-DTPA and protein markers.

P304

683-688

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/JNNP.54.8.683

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

54

http://www.w3.org/2001/XMLSchema#string

P577

1991-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

21214932

http://www.w3.org/2001/XMLSchema#string

P698

1940938

http://www.w3.org/2001/XMLSchema#string

P921

multiple sclerosis

P932

1014470

http://www.w3.org/2001/XMLSchema#string